Clinical trials
Phase 3 Cardiomyopathy, Hypertrophic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 5 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Cytokinetics | 2 |
| National Institute of Cardiology, Warsaw, Poland | 2 |
| Bayer | 1 |
| Braveheart Bio, Inc. | 1 |
| Corxel Pharmaceuticals | 1 |
| Heart Metabolics Limited | 1 |
| Lexicon Pharmaceuticals | 1 |
| LianBio LLC | 1 |
| MyoKardia, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 21 |
| Heart Failure | 2 |
| Arrhythmias, Cardiac | 1 |
| Atrial Fibrillation | 1 |
| Death, Sudden, Cardiac | 1 |
Trials
Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.